These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 19962921)

  • 21. Utilization of Sunitinib for Renal Cell Cancer: an Egyptian University hospital experience.
    M Eel D
    Asian Pac J Cancer Prev; 2016; 17(7):3161-6. PubMed ID: 27509945
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Advanced sarcomatoid renal cell carcinoma effectively treated with sunitinib: report of a case].
    Tsuchiyama K; Ito H; Ishida H; Itoh H; Yokoyama O
    Hinyokika Kiyo; 2011 Nov; 57(11):615-8. PubMed ID: 22166824
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effect of Sunitinib therapy on immune function of patients with advanced renal cell carcinoma].
    Xian P; Li Y; Zhou H; Luo H; Liu N; Dai JY
    Zhonghua Wai Ke Za Zhi; 2016 Oct; 54(10):741-745. PubMed ID: 27686636
    [No Abstract]   [Full Text] [Related]  

  • 24. Response to sorafenib in a patient with metastatic xp11 translocation renal cell carcinoma.
    Hou MM; Hsieh JJ; Chang NJ; Huang HY; Wang HM; Chuang CK; Hsu T; Chang JW
    Clin Drug Investig; 2010; 30(11):799-804. PubMed ID: 20635828
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acquired resistance to sunitinib in human renal cell carcinoma cells is mediated by constitutive activation of signal transduction pathways associated with tumour cell proliferation.
    Sakai I; Miyake H; Fujisawa M
    BJU Int; 2013 Jul; 112(2):E211-20. PubMed ID: 23305097
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combined positron emission tomography/computed tomography in sunitinib therapy assessment of patients with metastatic renal cell carcinoma.
    Revheim ME; Winge-Main AK; Hagen G; Fjeld JG; Fosså SD; Lilleby W
    Clin Oncol (R Coll Radiol); 2011 Jun; 23(5):339-43. PubMed ID: 21134733
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinical study of Sunitinib in the treatment of metastatic renal clear cell carcinoma: a single center 23 cases experience].
    Li XS; Song Y; Gong K; Zhang Q; Yu W; Song G; Zhao Z; Zhang Z; Wang G; Zhou LQ; He ZS; Jin J
    Zhonghua Wai Ke Za Zhi; 2010 Mar; 48(5):375-7. PubMed ID: 20450612
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [A case of recurrent intracaval renal cell carcinoma effectively treated with sunitinib].
    Komeya M; Matsumoto T; Fujinami K; Senga Y; Asakura T; Goto A
    Hinyokika Kiyo; 2010 Sep; 56(9):499-503. PubMed ID: 20940524
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sorafenib in patients with metastatic renal cell carcinoma refractory to either sunitinib or bevacizumab.
    Garcia JA; Hutson TE; Elson P; Cowey CL; Gilligan T; Nemec C; Dreicer R; Bukowski RM; Rini BI
    Cancer; 2010 Dec; 116(23):5383-90. PubMed ID: 20806321
    [TBL] [Abstract][Full Text] [Related]  

  • 30. First-Line sunitinib in patients with renal cell carcinoma (RCC) in von Hippel-Lindau (VHL) disease: clinical outcome and patterns of radiological response.
    Roma A; Maruzzo M; Basso U; Brunello A; Zamarchi R; Bezzon E; Pomerri F; Zovato S; Opocher G; Zagonel V
    Fam Cancer; 2015 Jun; 14(2):309-16. PubMed ID: 25391617
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Outcome of patients with renal cell carcinoma metastatic to the brain treated with sunitinib without local therapy.
    Lim ZD; Mahajan A; Weinberg J; Tannir NM
    Am J Clin Oncol; 2013 Jun; 36(3):258-60. PubMed ID: 22441343
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of hemodialyzed patients with sunitinib in renal cell carcinoma.
    Park S; Lee J; Park SH; Park JO; Kang WK; Park YS; Cho JH; Lim HY
    Chemotherapy; 2010; 56(6):485-91. PubMed ID: 21099221
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sequential use of the tyrosine kinase inhibitors sorafenib and sunitinib in metastatic renal cell carcinoma: a retrospective outcome analysis.
    Eichelberg C; Heuer R; Chun FK; Hinrichs K; Zacharias M; Huland H; Heinzer H
    Eur Urol; 2008 Dec; 54(6):1373-8. PubMed ID: 18692304
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative efficacy of sunitinib versus sorafenib as first-line treatment for patients with metastatic renal cell carcinoma.
    Park SJ; Lee JL; Park I; Park K; Ahn Y; Ahn JH; Lee DH; Ahn S; Song C; Hong JH; Kim CS; Ahn H
    Chemotherapy; 2012; 58(6):468-74. PubMed ID: 23548259
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [A case of myocardiac metastasis of clear cell renal carcinoma successfully treated with sunitinib].
    Tatenuma T; Yao M; Sakata R; Sano F; Makiyama K; Nakaigawa N; Nakayama T; Inayama Y; Kubota Y
    Hinyokika Kiyo; 2013 Feb; 59(2):97-101. PubMed ID: 23552751
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Utilizing pre-therapy clinical schema and initial CT changes to predict progression-free survival in patients with metastatic renal cell carcinoma on VEGF-targeted therapy: a preliminary analysis.
    Smith AD; Shah SN; Rini BI; Lieber ML; Remer EM
    Urol Oncol; 2013 Oct; 31(7):1283-91. PubMed ID: 21956044
    [TBL] [Abstract][Full Text] [Related]  

  • 37. When tyrosine kinase inhibitor sunitinib can be discontinued in metastatic renal cell carcinoma to pancreas: a case report.
    Sbitti Y; Debbagh A; Slimani K; Mahi M; Errihani H; Ichou M
    J Med Case Rep; 2018 Mar; 12(1):80. PubMed ID: 29554941
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multikinase inhibitors in metastatic renal cell carcinoma: indirect comparison meta-analysis.
    Leung HW; Chan AL
    Clin Ther; 2011 Jun; 33(6):708-16. PubMed ID: 21704235
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of IL13RA2 in Sunitinib Resistance in Clear Cell Renal Cell Carcinoma.
    Shibasaki N; Yamasaki T; Kanno T; Arakaki R; Sakamoto H; Utsunomiya N; Inoue T; Tsuruyama T; Nakamura E; Ogawa O; Kamba T
    PLoS One; 2015; 10(6):e0130980. PubMed ID: 26114873
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sunitinib for metastatic renal cell carcinoma.
    Mukherji D; Larkin J; Pickering L
    Future Oncol; 2010 Sep; 6(9):1377-85. PubMed ID: 20919823
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.